These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38972092)

  • 1. End-to-end offline reinforcement learning for glycemia control.
    Beolet T; Adenis A; Huneker E; Louis M
    Artif Intell Med; 2024 Aug; 154():102920. PubMed ID: 38972092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index.
    Lee MH; Vogrin S; Jones TW; O'Neal DN
    J Diabetes Sci Technol; 2024 Jul; 18(4):764-770. PubMed ID: 38372246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Offline reinforcement learning for safer blood glucose control in people with type 1 diabetes.
    Emerson H; Guy M; McConville R
    J Biomed Inform; 2023 Jun; 142():104376. PubMed ID: 37149275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Offline Deep Reinforcement Learning and Off-Policy Evaluation for Personalized Basal Insulin Control in Type 1 Diabetes.
    Zhu T; Li K; Georgiou P
    IEEE J Biomed Health Inform; 2023 Oct; 27(10):5087-5098. PubMed ID: 37607154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.
    Thivolet C; Lebbar M; Perge K; Nicolino M; Villar-Fimbel S
    J Diabetes Sci Technol; 2024 Sep; 18(5):1251-1252. PubMed ID: 39076117
    [No Abstract]   [Full Text] [Related]  

  • 6. Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    Sperling MA; Laffel LM
    N Engl J Med; 2022 Mar; 386(12):1155-1164. PubMed ID: 35320645
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy.
    Bukara-Radujkovic G; Miljkovic V
    Front Endocrinol (Lausanne); 2024; 15():1388245. PubMed ID: 38957442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes with MiniMed
    Abraham MB; Smith GJ; Dart J; Davis EA; Jones TW
    Diabetes Technol Ther; 2024 May; 26(5):341-345. PubMed ID: 38215208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments.
    Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2018 Jun; 65(6):1281-1290. PubMed ID: 28866479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the basal/bolus ratio on continuous glucose monitoring parameters in patients with type 1 diabetes.
    González-Vidal T; Rivas-Otero D; Ramos-Ruiz G; Agüeria-Cabal P; Lambert C; Ares J; Delgado E; Menéndez-Torre E
    Diabetes Obes Metab; 2024 Aug; 26(8):3482-3485. PubMed ID: 38826106
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.
    Rizzi A; Tartaglione L; Lucaccini Paoli L; Leo ML; Popolla V; Viti L; Barberio A; Di Leo M; Pontecorvi A; Pitocco D
    Diabetes Obes Metab; 2024 Sep; 26(9):4078-4086. PubMed ID: 39010292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Real-Time Advisor-a Decision Support Application for Insulin Therapy Coupled With the Continuous Glucose Monitoring: Impact on Glycemic Control on People With Type 1 Diabetes.
    Pflaum R; Vaduva P; Allard M; Derrien C; Lefebvre MA; Esvan M; Guilhem I; Guenego A
    J Diabetes Sci Technol; 2024 Sep; 18(5):1253-1255. PubMed ID: 39044532
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing blood glucose levels with a hybrid closed-loop system in a patient with type 1 diabetes mellitus on enteral nutrition: A case report.
    Carnino E; Lablanche S; Bétry C
    Diabetes Res Clin Pract; 2024 Aug; 214():111789. PubMed ID: 39053692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of advanced hybrid closed loop systems in children with type 1 diabetes younger than 6 years.
    Rapini N; Martino M; Arnaldi C; Deodati A; Anagnostopoulou L; Amodeo ME; Ciampalini P; Pampanini V; Lorubbio A; Tosini D; Cianfarani S; Schiaffini R
    Front Endocrinol (Lausanne); 2024; 15():1382920. PubMed ID: 38836230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study.
    Munda A; Kovacic C; Pongrac Barlovic D
    J Diabetes Complications; 2024 Aug; 38(8):108795. PubMed ID: 38878423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
    Da Prato G; Csermely A; Pilati M; Carletti L; Rinaldi E; Donà S; Santi L; Negri C; Bonora E; Moghetti P; Trombetta M
    J Diabetes Sci Technol; 2024 Sep; 18(5):1256-1257. PubMed ID: 39081024
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Donovan LE; Bell RC; Feig DS; Lemieux P; Murphy HR; Sigal RJ; Ho J; Virtanen H; Crawford S; Yamamoto JM
    Diabetologia; 2024 Oct; 67(10):2154-2159. PubMed ID: 39028360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.
    Benhalima K; Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C
    Lancet Diabetes Endocrinol; 2024 Jun; 12(6):390-403. PubMed ID: 38697182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience.
    Resmini E; Zarra E; Dotti S; Rotondi G; Cornaghi AV; Madaschi S; Cimino E; Massari G; Pezzaioli LC; Buoso C; Sandri M; Girelli A
    Eur J Med Res; 2024 Jul; 29(1):365. PubMed ID: 39004734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.